GlassScriptPhysician profile
Donald B Hatcher
NPI 1932224938
$582.17
in general payments reported to CMS, 2019-2025
13 companies · $109 in 2025
The $109 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2021: $108 · 2022: $108 · 2023: $51.31 · 2024: $47.77 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $120.87 | 2019 | |
| Penumbra, INC. | $109.08 | 2025 | Indigo System |
| Redhill Biopharma INC. | $91.48 | 2021 | |
| Janssen Pharmaceuticals, INC | $63.24 | 2021-2024 | Spravato |
| Csl Behring | $51.51 | 2019-2022 | |
| Pfizer INC. | $28.74 | 2019-2023 | |
| Purdue Pharma L.P. | $18.65 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.38 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.29 | 2024 | Farxiga |
| Bioxcel Therapeutics, INC. | $18.09 | 2023 | Igalmi |
| Inari Medical, INC. | $17.14 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.46 | 2019 | |
| Chiesi USA, INC. | $13.24 | 2024 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Hatcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.